MIIKANA THERAPEUTICS
Miikana Therapeutics is a private held biotechnology company. It is a biopharmaceutical company focuses on the discovery and development of medicines for the treatment of cancer.
MIIKANA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Fremont, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Contact:
(510)818-2751
Total Funding:
7.25 M USD
Similar Organizations
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Tapestry Pharmaceuticals
Tapestry Pharmaceuticals is a biopharmaceutical company focused on the development of proprietary therapies for the treatment of cancer.
Investors List
Aravis Ventures
Aravis Ventures investment in Series A - Miikana Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Miikana Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Miikana Therapeutics
Aravis Ventures
Aravis Ventures investment in Series A - Miikana Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Miikana Therapeutics
More informations about "Miikana Therapeutics"
Miikana Therapeutics - Crunchbase Company Profile & Funding
Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer.See details»
Miikana Therapeutics - VentureRadar
Miikana Therapeutics (Freemont, USA) is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer. Miikana was acquired by EntreMed …See details»
Miikana Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Miikana Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Miikana Therapeutics - Funding, Financials, Valuation & Investors
Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer.See details»
Miikana Therapeutics acquired by CASI Pharmaceuticals
Miikana Therapeutics Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer. Acquiring Organization: CASI …See details»
Miikana Therapeutics Inc - Company Profile and News
Miikana Therapeutics Inc. develops therapeutics. The Company specializes in discovery and development of medicines for the treatment of cancer. Miikana Therapeutics conducts …See details»
Miikana Therapeutics, Inc - VentureRadar
Website: http://www.miikana.com Efficas USA Privately Held Efficas natural products are designed to provide consumers with meaningful quality of life benefits by working with the …See details»
Miikana Therapeutics - Products, Competitors, Financials, …
Miikana has built an oncology pipeline through a strategy that included both in-licensing clinical and preclinical compounds with distinct mechanisms of action, and generating medicinal …See details»
Miikana Therapeutics Inc. :: HBW Insight
Jan 1, 2005 · Miikana Therapeutics Inc. is focused on in-licensing late-stage oncology compounds that fit well with the staff's expertise in cancer pathways effecting apoptosis and mitotic …See details»
EntreMed, Inc. To Acquire Miikana Therapeutics - BioSpace
Dec 22, 2005 · The acquisition of Miikana will expand and complement EntreMed’s oncology franchise. Miikana’s oncology pipeline includes clinical and pre-clinical drug candidates: * MKC …See details»
Miikana Therapeutics - Tech Stack, Apps, Patents & Trademarks
Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer.See details»
Miikana Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Feb 18, 2013 · Miikana Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
EntreMed, Inc. Completes Acquisition Of Miikana Therapeutics
ROCKVILLE, Md., Jan. 11 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and …See details»
Miikana Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Miikana Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
EntreMed Secures $5.1 Million in Registered Direct Offering and …
Sep 8, 2010 · EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer. ENMD-2076 …See details»
Miikana Therapeutics - Crunchbase
Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer.See details»
Executive Team - Protagonist Therapeutics Inc.
Previously, he was the Chief Executive Officer and Co-founder of Miikana Therapeutics, an oncology based company, from 2003 until acquired by Entremed (later renamed CASI …See details»
Miikana Therapeutics - Updates, News, Events, Signals & Triggers
Miikana Therapeutics is a clinically-driven biopharmaceutical company focused on targeted medicines for the treatment of cancer.See details»
Research programme: therapeutic antibodies - Miikana/Light …
Miikana Therapeutics (EntreMed) and NovImmune (now Light Chain Bioscience) were collaborating to develop fully human antibody-based therapeutics for theSee details»